https://pharminent.com/81875-2/ 2026-06-12T23:21:39Z Pharminent en 2026-06-12T23:10:36Z Blog https://pharminent.com/81872-2/ 2026-06-12T20:15:54Z Pharminent en 2026-06-12T20:15:51Z Blog https://pharminent.com/81869-2/ 2026-06-12T21:52:54Z Pharminent en 2026-06-12T20:07:13Z Blog https://pharminent.com/glp-1-competitive-market/glp-1-competitive-market-digest-weekly-june-12-2026/ 2026-06-12T19:37:16Z Pharminent en GLP-1 Competitive Market Digest • Weekly • June 12, 2026 2026-06-12T19:37:14Z Blog https://pharminent.com/glp-1-competitive-market/glp-1-competitive-market-digest-weekly-june-5-2026/ 2026-06-12T19:36:19Z Pharminent en GLP-1 Competitive Market Digest • Weekly • June 5, 2026 2026-06-12T19:36:17Z Blog https://pharminent.com/glp-1-competitive-market/glp-1-competitive-market-digest-weekly-may-29-2026/ 2026-06-12T19:35:00Z Pharminent en GLP-1 Competitive Market Digest • Weekly • May 29, 2026 2026-06-12T19:34:57Z Blog https://pharminent.com/strategic-news-watch/strategic-news-watch-june-12-2026/ 2026-06-12T17:45:27Z Pharminent en Strategic News Watch • June 12, 2026 2026-06-12T17:45:25Z Blog https://pharminent.com/market-access/market-access-intelligence-weekly-digest-june-12-2026/ 2026-06-12T12:22:11Z Pharminent en MARKET ACCESS INTELLIGENCE • Weekly Digest • June 12, 2026 2026-06-12T12:22:09Z Blog https://pharminent.com/novo-nordisk-comeback-stirs-as-wegovy-pill-wins-uk-approval/ 2026-06-12T16:34:24Z Pharminent en Novo Nordisk comeback stirs as Wegovy pill wins UK approval 2026-06-12T10:55:31Z Blog https://pharminent.com/rare-disease-gene-therapy/rare-disease-gene-therapy-digest-june-11-2026/ 2026-06-11T22:29:44Z Pharminent en Rare Disease & Gene Therapy Digest • June 11, 2026 2026-06-11T22:29:43Z Blog https://pharminent.com/81810-2/ 2026-06-11T22:26:29Z Pharminent en 2026-06-11T22:17:17Z Blog https://pharminent.com/81804-2/ 2026-06-12T23:22:31Z Pharminent en 2026-06-11T20:05:53Z Blog https://pharminent.com/strategic-news-watch/strategic-news-watch-june-11-2026/ 2026-06-11T17:46:29Z Pharminent en Strategic News Watch • June 11, 2026 2026-06-11T17:46:23Z Blog https://pharminent.com/sky-high-parabilis-kailera-ipos-spur-optimism-but-only-for-derisked-biotechs/ 2026-06-11T15:35:00Z Pharminent en Sky-high Parabilis, Kailera IPOs spur optimism--but only for derisked biotechs 2026-06-11T13:44:20Z Blog https://pharminent.com/jj-adds-rare-disease-waiha-to-imaavys-potential-uses/ 2026-06-11T15:35:01Z Pharminent en J&J adds rare disease wAIHA to Imaavy's potential uses 2026-06-11T13:03:57Z Blog https://pharminent.com/novartis-gets-win-for-another-avidity-muscular-dystrophy-aoc/ 2026-06-11T15:35:04Z Pharminent en Novartis gets win for another Avidity muscular dystrophy AOC 2026-06-11T12:04:17Z Blog https://pharminent.com/takedas-4b-tyk2-drug-tops-bristol-myers-sotyktu-in-head-to-head-test/ 2026-06-11T15:39:53Z Pharminent en Takeda's $4B TYK2 drug tops Bristol Myers' Sotyktu in head-to-head test 2026-06-11T11:00:00Z Blog